Imaging services chain Medical Resources has made a number of moves to strengthen its management team. The company named Lawrence Ramaekers to its previously vacant post of CEO and has also begun a review of its related-party transactions in response to
Imaging services chain Medical Resources has made a number of moves to strengthen its management team. The company named Lawrence Ramaekers to its previously vacant post of CEO and has also begun a review of its related-party transactions in response to concerns from shareholders and members of senior management.
Ramaekers, who will serve as acting CEO, is a principal at management consulting firm Jay Alix & Associates and specializes in interim management assignments. He has previously worked as CEO at national restaurant chain Family Restaurants, and as COO of National Car Rental.
The investigation of the company's related-party transactions will focus principally on fees for investment banking, advisory, and other services paid to 712 Advisory Services, an affiliate of Medical Resources chairman Gary Siegler. In addition to assessing the manner by which the company considers related-party transactions, the review will examine the fairness of all such transactions and the adequacy of their disclosure. The review will also develop recommendations on what changes, if any, should be made to the company's procedures.
In the quarter ended September 30, 712 Advisory Services received around $1 million for services rendered involving six different acquisitions with an aggregate transaction value of approximately $33 million, according to Medical Resources. All earlier payments to 712 have previously been reported on a timely basis, according to the firm. Siegler and 712 believe that all of its financial advisory fees are and were proper, but will nevertheless abide by the findings of the independent review, according to the company.
Medical Resources has retained outside counsel to investigate the 712 transactions. A committee of directors formed by the board will initially oversee the review, although two new directors who will soon be added to the board will assume ultimate responsibility for the review.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.